Enzyre B.V.

Enzyre, based in Nijmegen, in The Netherlands is developing a near patient diagnostic device focused on blood coagulation. Enzyre’s platform technology is unique as it requires just a small volume of blood and can measure twelve different reactions simultaneously with high sensitivity and specificity without any laboratory infrastructure; at home, on the road or in a critical care setting. This offers enormous benefits to patients in that it can avoid crisis situations driven by changes in coagulation status; provides ease of mind for patients; empower patients to optimize treatment themselves; can be quick turnaround tool in the clinical setting; and can reduce GP visits.

www.enzyre.com